- Monoclonal Antibody Therapy in Haematological Malignancies2002 | First Faculty of Medicine
- Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis2016 | First Faculty of Medicine
- Anti-IgE monoclonal antibody therapy for severe bronchial asthma and other allergic disease2019 | Second Faculty of Medicine
- Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes2022 | First Faculty of Medicine
- The Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved in PCR Negative Patients after High Dose Therapy with Autologous Stem Cell Transplantation or Monoclonal Antibody TherapyPublication without faculty affiliation
- AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma2019 | First Faculty of Medicine
- Future therapy of severe refractory asthma2017 | Publication without faculty affiliation
- Current application of ritusimab in pharmacotherapy2015 | Publication without faculty affiliation
- Therapeutic monoclonal antibodies in clinical laboratory2017 | First Faculty of Medicine
- Treatment of nonHodgkin lymphoma with monoclonal antibodies in 20192019 | Faculty of Medicine in Hradec Králové
- Monitoring of the pharmacokinetics of biological drugs in inflammatory bowel disease2018 | First Faculty of Medicine
- Immunotherapy - Perspectives of Application in the Therapy of Ovarian Carcinomas2004 | Second Faculty of Medicine
- Myasthenia gravis, castleman disease, pemphigus, and anti-phospholipid syndrome2013 | First Faculty of Medicine
- Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient2023 | First Faculty of Medicine
- Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use2015 | First Faculty of Medicine